Emili Montserrat
- Genetics top 0.01%
- Chronic Lymphocytic Leukemia Research 165
- Pathology and Forensic Medicine top 0.02%
- Lymphoma Diagnosis and Treatment 144
- Hematology top 0.1%
- Multiple Myeloma Research and Treatments 26
- Hematopoietic Stem Cell Transplantation 26
- Acute Myeloid Leukemia Research 23
- Chronic Myeloid Leukemia Treatments 22
- Immunology top 0.2%
- Immunodeficiency and Autoimmune Disorders 58
- Oncology top 0.5%
- Viral-associated cancers and disorders 28
Emili Montserrat
291 papers receiving 15.9k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Genetics 10.5k
- Pathology and Forensic Medicine 9.4k
- Hematology 3.8k
- Immunology 5.3k
- Oncology 4.1k
Countries citing papers authored by Emili Montserrat
This map shows the geographic impact of Emili Montserrat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emili Montserrat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emili Montserrat more than expected).
Fields of papers citing papers by Emili Montserrat
This network shows the impact of papers produced by Emili Montserrat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emili Montserrat. The network helps show where Emili Montserrat may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emili Montserrat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 14 | |
| 2 | 2019 | 5 | |
| 3 | 2019 | 21 | |
| 4 | 2018 | 39 | |
| 5 | 2017 | 66 | |
| 6 | 2013 | 3 | |
| 7 | 2012 | 133 | |
| 8 | 2009 | 246 | |
| 9 | 2008 | 60 | |
| 10 | 2008 | 95 | |
| 11 | The purine nucleoside phosphorylase inhibitor forodesine induces p53-independent apoptosis in chronic lymphocytic leukemia through caspase-8 activation, Mcl-1 downregulation, conformational changes of Bax and Bak and ROS generation. | 2007 | 2 |
| 12 | 2007 | 69 | |
| 13 | 2006 | 91 | |
| 14 | Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation. | 2006 | 51 |
| 15 | 2006 | 89 | |
| 16 | 1999 | 11 | |
| 17 | 1999 | 143 | |
| 18 | 1999 | 4 | |
| 19 | 1989 | 13 | |
| 20 | 1988 | 13 |
About Emili Montserrat
Emili Montserrat is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 296 papers that have together received 16.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (165 papers), Lymphoma Diagnosis and Treatment (144 papers), Immunodeficiency and Autoimmune Disorders (58 papers), Viral-associated cancers and disorders (28 papers), Multiple Myeloma Research and Treatments (26 papers), Hematopoietic Stem Cell Transplantation (26 papers), Acute Myeloid Leukemia Research (23 papers) and Chronic Myeloid Leukemia Treatments (22 papers). The work is most often cited by research in Genetics (10.5k citations), Pathology and Forensic Medicine (9.4k citations) and Hematology (3.8k citations). Emili Montserrat has collaborated with scholars based in Spain, Italy and United States. Frequent co-authors include Elı́as Campo, Neus Villamor, Dolors Colomer, Michael Hallek, Francesc Bosch, Armando López‐Guillermo, Peter Hillmen, Hartmut Döhner, Michael J. Keating and Federico Caligaris‐Cappio. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.